Results 211 to 220 of about 346,610 (333)

Direct oral anticoagulants in very elderly and high-bleeding-risk patients with atrial fibrillation often excluded from oral anticoagulation therapy: a nationwide population-based cohort study. [PDF]

Europace
Go YH, Lee SR, Lee SR, Choi EK, Ahn HJ, Han KD, Oh S, Lip GYH.   +7 more
europepmc   +1 more source

The Case for Anticoagulant Therapy [PDF]

, 1964
Irving S. Wright
openalex   +1 more source

Risk of Infections with SGLT2 Inhibitors Versus DPP4 Inhibitors: A Population‐Based Cohort Study Using Antibiotic Dispensing Data

Clinical Pharmacology &Therapeutics, EarlyView.
This study compared the number and cumulative dose of antibiotic dispensings among new users of sodium–glucose cotransporter‐2 (SGLT2) inhibitors and dipeptidyl peptidase‐4 (DPP4) inhibitors following hospital discharge in individuals with type 2 diabetes.
Maria J. Alfonso Arvez, George S. Q. Tan, Sam Wade, Zanfina Ademi, Jenni Ilomäki, J. Simon Bell   +5 more
wiley   +1 more source

Correction: Prophetic Medicine-Nigella Sativa (Black Cumin Seeds) - Potential Herb for COVID-19?

Journal of Pharmacopuncture, 2020
Naina Mohamed Pakkir Maideen
doaj   +1 more source

Optimizing care for patients after major anticoagulant-related bleeding: a narrative review and proposal for a clinical care pathway. [PDF]

Res Pract Thromb Haemost
Krommenhoek J, Camilleri E, van Mens T, Huisman M, Kruyt N, van Etten E, Tushuizen M, Trines S, van Rein N, Aukema A, Klok E, den Exter P.   +11 more
europepmc   +1 more source

Effectiveness and Safety of Reduced‐Dose Prasugrel in an East Asian Population: PRASFIT‐ACS Emulation Using National Health Insurance Claims Data

Clinical Pharmacology &Therapeutics, EarlyView.
Prasugrel is recommended for acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI). However, East Asians exhibit a stronger antiplatelet response, raising concerns about bleeding risks with standard dosing. This retrospective cohort study evaluated the real‐world effectiveness and safety of reduced‐dose prasugrel in
Li‐Wen Huang, Yee‐Jen Wu, Fang‐Ju Lin, Chien‐Chih Wu, Hsin‐Yi Huang, Chi‐Chuan Wang, Xiaojuan Li   +6 more
wiley   +1 more source

Development of a predictive model for nafamostat mesylate dosing in hemodialysis. [PDF]

BMC Nephrol
Lee SY, Kim JS, Kim HJ, Yoon JM, Seo MJ, Lee JY, Choi KA, Lee KS, Choi AR, Ko SM, Seo KH, Kim HR.   +11 more
europepmc   +1 more source

THE EFFECT OF ANTICOAGULANTS ON DETERMINATIONS OF INORGANIC PHOSPHATE AND PROTEIN IN PLASMA

, 1932
O. H. Gaebler
openalex   +1 more source

Potentiation of Anticoagulants [PDF]

, 1967
J. D. Eddy, Jane R. MacKinnon
openalex   +1 more source

Results of the ACCOuNT Trial: A Multi‐Institutional Prospective Pharmacogenomics Implementation Trial for African American Inpatients

Clinical Pharmacology &Therapeutics, EarlyView.
Pharmacogenomics implementation efforts have increased over the last decade, but no published prospective pharmacogenomics trials have formally evaluated utility in underrepresented populations. We present final results from the ACCOuNT trial, a multi‐institutional prospective study [NCT03225820] in which African American inpatients were genotyped and ...
Zhong Huang, Kevin J. O'Leary, Edith A. Nutescu, Matthew Jack, Thomas Chen, Gregory W. Ruhnke, James C. Lee, David George, Larry K. House, Randall Knoebel, Luke V. Rasmussen, Seth Hartman, Anish Choksi, Kiang‐Teck J. Yeo, Minoli A. Perera, Mark J. Ratain, David O. Meltzer, Peter H. O'Donnell   +17 more
wiley   +1 more source